Ron A. Wevers

Active 1977–2025

154
Papers
18,128
Citations
90
h-index
148
i10-index

Citations

Citations per year for Ron A. Wevers1978: 1 citations1979: 1 citations1984: 1 citations1986: 1 citations1987: 4 citations1989: 1 citations1990: 1 citations1993: 4 citations1994: 20 citations1995: 9 citations1996: 4 citations1997: 10 citations1998: 27 citations1999: 37 citations2000: 68 citations2001: 65 citations2002: 54 citations2003: 68 citations2004: 71 citations2005: 68 citations2006: 92 citations2007: 90 citations2008: 93 citations2009: 107 citations2010: 112 citations2011: 144 citations2012: 122 citations2013: 169 citations2014: 154 citations2015: 139 citations2016: 142 citations2017: 144 citations2018: 188 citations2019: 450 citations2020: 549 citations2021: 503 citations2022: 351 citations2023: 244 citations2024: 428 citations2025: 163 citations2026: 2 citations1980–1983: no citations, so these years are not shown1985: no citations, so this year is not shown1988: no citations, so this year is not shown1991–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,549 citing papers, 20.9% of this breakdownNetherlands: 580 citing papers, 7.8% of this breakdownUnited Kingdom: 563 citing papers, 7.6% of this breakdownGermany: 521 citing papers, 7% of this breakdownItaly: 382 citing papers, 5.2% of this breakdownFrance: 353 citing papers, 4.8% of this breakdownChina: 310 citing papers, 4.2% of this breakdownCanada: 294 citing papers, 4% of this breakdownSpain: 211 citing papers, 2.9% of this breakdownAustralia: 195 citing papers, 2.6% of this breakdownJapan: 189 citing papers, 2.6% of this breakdownSwitzerland: 188 citing papers, 2.5% of this breakdown
0%20.9%Other 27.9%

Fields

  • Biochemistry, Genetics and Molecular Biology46.4%
  • Medicine38.8%
  • Neuroscience4.5%
  • Nursing2.8%
  • Immunology and Microbiology2.1%
  • Environmental Science1.6%
  • Other3.8%

Topics

  • Metabolism and Genetic Disorders4.5%
  • Lysosomal Storage Disorders Research4%
  • Mitochondrial Function and Pathology3.3%
  • Glycosylation and Glycoproteins Research2.5%
  • Metabolomics and Mass Spectrometry Studies2.3%
  • Genomics and Rare Diseases1.9%
  • Other81.5%

Coauthors

All papers

Open in search
  1. Syndrome of Hepatic Cirrhosis, Dystonia, Polycythemia, and Hypermanganesemia Caused by Mutations in SLC30A10 , a Manganese Transporter in Man

    Authors: , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2012 cited by 378

  2. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes

    Authors: , , , , , , , , , , , , , - Diabetologia 2017 cited by 192

  3. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ming Lim, G.M.S. Mancini, Adela Della Marina, Loreto Martorell, Joe McMenamin, Marije Meuwissen, Helen Mundy, Nils‐Otto Nilsson, Axel Panzer, Bwee Tien Poll‐The, C. Rauscher, C. M. R. Rouselle, Inger Sandvig, T Scheffner, E. Sheridan, N. B. Simpson, Peter Sýkora, RJ Tomlinson, J Q Trounce, David Webb, Bernhard Weschke, Hans Scheffer, Michèl A.A.P. Willemsen - Brain 2010 cited by 413

  4. Next‐generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients

    Authors: , , , , , , , , , , , , , , , , , - Journal of Inherited Metabolic Disease 2018 cited by 204

  5. The frequency of lysosomal storage diseases in The Netherlands

    Authors: , , , , , , , - Human Genetics 1999 cited by 725

  6. Exome Sequencing and the Management of Neurometabolic Disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oluseye A. Ogunbayo, Bojana Rakić, Jacob Rozmus, Peter C. Ruben, Bryan Sayson, Saikat Santra, Kirk R. Schultz, Kathryn Selby, Paul Shekel, Sandra Sirrs, Cristina Skrypnyk, Andrea Superti‐Furga, Stuart E. Turvey, Margot I. Van Allen, David S. Wishart, Jiang Wu, John K. Wu, Dimitrios Zafeiriou, Leo A. J. Kluijtmans, Ron A. Wevers, Patrice Eydoux, Anna Lehman, Hilary Vallance, Sylvia Stöckler‐Ipsiroglu, Graham Sinclair, Wyeth W. Wasserman, Clara D.M. van Karnebeek - New England Journal of Medicine 2016 cited by 280

  7. Mutations in ATP6V1E1 or ATP6V1A Cause Autosomal-Recessive Cutis Laxa

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter K.C. Leung, Siavash Ghaderi‐Sohi, Paul Coucke, Sofie Symoens, Anne De Paepe, Christian Thiel, Tobias B. Haack, Fransiska Malfait, Éva Morava, Bert Callewaert, Ron A. Wevers - The American Journal of Human Genetics 2017 cited by 113

  8. Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia

    Authors: , , , , , , , , , , , , - Movement Disorders 2021 cited by 48

  9. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Johannes N. Spelbrink, Ron A. Wevers, Éva Morava, Arjan P.M. de Brouwer - Nature Genetics 2012 cited by 207

  10. CLPB Mutations Cause 3-Methylglutaconic Aciduria, Progressive Brain Atrophy, Intellectual Disability, Congenital Neutropenia, Cataracts, Movement Disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michèl A.A.P. Willemsen, Arjan P.M. de Brouwer, Holger Prokisch, Nicholas Katsanis, Ron A. Wevers - The American Journal of Human Genetics 2015 cited by 135

  11. Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start

    Authors: , , , , , , , , - Neurology 2018 cited by 130

  12. Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2017 cited by 130

  13. The membrane protein ANKH is crucial for bone mechanical performance by mediating cellular export of citrate and ATP

    Authors: , , , , , , , , , , - PLoS Genetics 2020 cited by 84

  14. Folate Receptor Alpha Defect Causes Cerebral Folate Transport Deficiency: A Treatable Neurodegenerative Disorder Associated with Disturbed Myelin Metabolism

    Authors: , , , , , , , , - The American Journal of Human Genetics 2009 cited by 281

  15. Mutations in DDHD2, Encoding an Intracellular Phospholipase A1, Cause a Recessive Form of Complex Hereditary Spastic Paraplegia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michèl A.A.P. Willemsen, Lisenka E.L.M. Vissers, Martin Lammens, Hans van Bokhoven, Han G. Brunner, Ron A. Wevers, Annette Schenck, Lihadh Al‐Gazali, Bert B.A. de Vries, Arjan P.M. de Brouwer - The American Journal of Human Genetics 2012 cited by 182

  16. How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Inherited Metabolic Disease 2022 cited by 73

  17. Performance of near-infrared spectroscopy in measuring local O2 consumption and blood flow in skeletal muscle

    Authors: , , , - Journal of Applied Physiology 2001 cited by 523

  18. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dimitrios Zafeiriou, Ron A. Wevers - Brain 2010 cited by 234

  19. NANS-mediated synthesis of sialic acid is required for brain and skeletal development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Rossi, Udo F. H. Engelke, Leo A. J. Kluijtmans, E. van der Heeft, G. Herma Renkema, Arjan de Brouwer, Karin Huijben, Fokje Zijlstra, Torben Heise, Thomas J. Boltje, Wyeth W. Wasserman, Carlo Rivolta, Sheila Unger, Dirk J. Lefeber, Ron A. Wevers, Andrea Superti‐Furga - Nature Genetics 2016 cited by 166

  20. ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joris A. Veltman, Tom H. Stevens, Dirk J. Lefeber - Nature Communications 2016 cited by 150

  21. Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical Practice

    Authors: , , , - PLoS ONE 2012 cited by 136

  22. CADmutations and uridine-responsive epileptic encephalopathy

    Authors: , , , , , , , , , , , , , , , , , , , , - Brain 2016 cited by 124

  23. Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nanda M. Verhoeven‐Duif, Maha S. Zaki, Ron A. Wevers - The American Journal of Human Genetics 2019 cited by 86

  24. The role of the clinician in the multi‐omics era: are you ready?

    Authors: , , , , , , , , , , , , - Journal of Inherited Metabolic Disease 2018 cited by 81